Inside an Individual’s Physiological Signature
Originally published in Medical Device & Technology
Originally published in Applied Clinical Trials
physIQ has announced a strategic collaboration with InCarda Therapeutics, Inc. Syneos Health recommended physIQ’s monitoring solution to help advance InCarda’s clinical study of InRhythm™ (orally inhaled flecainide) in patients with atrial fibrillation.
Read more about the new partnership here.
Originally published in Medical Device & Technology
Originally published in Pixel Scientia Labs
Originally published in Crain's Chicago